Natterman Hoestdrank Suikervrij (Bromhexine Hydrochloride)

Bromhexine Hydrochloride, the active ingredient in Natterman Hoestdrank Suikervrij, is a mucolytic presented as an oral liquid for oral use. It helps loosen thick mucus in the respiratory tract, facilitating expectoration in patients with productive cough. GNH USA supplies Natterman Hoestdrank Suikervrij as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Bromhexine Hydrochloride acts on the respiratory system to reduce mucus viscosity and aid clearance. - Acute bronchitis: loosens thick mucus, improving cough effectiveness. - Chronic bronchitis: assists in regular mucus clearance, reducing cough frequency. - COPD exacerbations: facilitates expectoration of secretions, supporting airway patency.

Bromhexine Hydrochloride may cause several adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Vomiting: occasional expulsion of stomach contents. - Diarrhea: loose stools occurring after dosing. - Abdominal discomfort: cramping or pain in the stomach area. - Taste disturbance: altered or unpleasant taste sensation. - Rash: mild skin redness or itching.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response requiring immediate medical attention. - Stevens‑Johnson syndrome: rare severe skin eruption. - Hepatic dysfunction: abnormal liver enzyme elevations. - Eosinophilic pneumonia: rare inflammatory lung condition.

Before using bromhexine, consider the following safety measures. - Pregnancy: consult a healthcare professional before use. - Breastfeeding: use with caution and under medical advice. - Renal impairment: dose adjustment may be required. - Asthma: monitor for possible bronchospasm. - Drug interactions: review all concomitant medications. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Bromhexine may interact with other medicines; awareness helps avoid complications.

Major Interactions (Avoid): - Codeine‑containing antitussives: may diminish mucolytic effect. - Other mucolytics: increased risk of gastrointestinal irritation.

Moderate Interactions (Monitor Closely): - Macrolide antibiotics: potential increase in bromhexine plasma levels. - Antihistamines: may enhance sedation. - Bronchodilators: monitor respiratory response for additive effects.